TY  - CONF

T1  - Cost-effectiveness of zoledronic acid in the prevention of fractures in postmenopausal women with early breast cancer receiving aromatase inhibitor: Application to the United Kingdom

JO  - EJC SUPPLEMENTS

PY  - 2007/09/01

AU  - Logman F

AU  - Heeg B

AU  - Botteman MF

AU  - Marfatia AA

AU  - Van Hout BA

ED  - 

VL  - 5

IS  - 4

SP  - 156

EP  - 156

Y2  - 2024/12/22

ER  -